Growth factors - Pharmaceutical Biotechnology: Concepts and Aapplications - page 291

Epidermal growth factor and platelet-derived growth factor
Board, R. and Jayson, G. 2005. Platelet-derived growth factor receptor (PDGFR): a target for anti cancer
therapeutics. Drug Resistance Updates 8 (1-2), 75-83.
Boonstra, J., Rijken, P., Humbel, B., Cremers, F., Verkleij, A., and van Bergen en Henegouwen, P. 1995. The
epidermal growth factor. Cell Biology International 19 (5), 413-430.
Johnstone, P. 2002. The epidermal growth factor receptor: a new target for anticancer therapy - introduction.
Current Problems in Cancer 26 (3), 114-164.
Kane, S. 2006. Cancer therapies targeted to the epidermal growth factor receptor and its family members. Expert
Opinion on Therapeutic Patents 16 (2), 147-164.
Leserer, M., Gschwind, A., and Ullrich, A. 2000. Epidermal growth factor receptor signal transactivation. IUBMB
Life 49 (5), 405-430.
Shih, A. and Holland, E. 2006. Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Letters
232 (2), 139-147.
Wakeling, A. 2002. Epidermal growth factor receptor tyrosine kinase inhibitors. Current Opinion in Pharmacology
2 (4), 382-387.
Fibroblast growth factor/transforming growth factor
Dennler, S., Goumans, M.J., and ten Dijke, P. 2002. Transforming growth factor beta signal transduction. Journal
of Leukocyte Biology 71 (5), 731-740.
Hu, X. and Zuckerman, K. 2001. Transforming growth factor: signal transduction pathways, cell cycle mediation,
and effects on hematopoiesis. Journal of Hematotherapy and Stem Cell Research 10 (1), 67-74.
Imel, E. and Econs, M. 2005. Fibroblast growth factor 23: roles in health and disease. Journal of the American
Society of Nephrology 16 (9), 2565-2575.
Kim, I.Y., Kim, M.M., and Kim, S.J. 2005. Transforming growth factor beta: biology and clinical relevance.
Journal of Biochemistry and Molecular Biology 38 (1), 1-8.
Le, Y., Yu, X., Ruan, L., Wang, O., Qi, D., Zhu, J., Lu, X., Kong, Y., Cai, K., Pang, S., Shi, X., and Wang,
J.M. 2005. The immunopharmacological properties of transforming growth factor beta. International
Immunopharmacology 9 (13-14), 1771-1782.
Narayan, S., Thangasamy, T., and Balusu, R. 2005. Transforming growth factor beta receptor signaling in cancer.
Frontiers in Bioscience 10 , 1135-1145.
Powers, C.J., McLeskey, S.W., and Wellstein, A. 2000. Fibroblast growth factors, their receptors and signalling.
Endocrine Related Cancer 7 (3), 165-197.
Neurotrophic and related factors
Allen, S. and Dawbarn, D. 2006. Clinical relevance of the neurotropins and their receptors. Clinical Science
110 (2), 175-191.
Butte, M. 2001. Neurotrophic factor structure reveals clues to evolution, binding, specifi city and receptor
activation. Cellular and Molecular Life Sciences 58 (8), 1003-1013.
Chao, M.V., Rajagopal, R., and Lee, F.S. 2006. Neurotrophin signaling in health and disease. Clinical Science
110 (2), 167-173.
Fu, S. and Gordon, T. 1997. The cellular and molecular basis of peripheral nerve regeneration. Molecular
Neurobiology 14 , 67-116.
Haque, N.S.K., Borghesani, P., and Isacson, O. 1997. Therapeutic strategies for Huntington's disease, based on a
molecular understanding of the disorder. Molecular Medicine Today 3 (4), 175-183.